Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial
Contact your GP or trial team if: Dizziness is persistent, worsening, or significantly affecting your daily activities You experience dizziness accompanied by nausea, vomiting, or an inability to maintain adequate fluid intake You notice dizziness occurring consistently when standing up, which may indicate orthostatic hypotension requiring assessment You are also taking antidiabetic medications and suspect your blood glucose may be low If you are unable to reach your GP or trial team and need urgent advice, call NHS 111 (available 24 hours a day)
Common Peptides Side Effects Peptide-based treatments, whether topical or injectable , are generally considered safe when administered by professionals who have received proper Peptide Training
Solutions: Rotate injection sites more frequently Use new needle every time Clean site thoroughly with alcohol Let alcohol dry before injecting If persistent, reduce dose or switch to oral Usually harmless: Minor reactions common Should resolve within hours to days Not dangerous unless signs of infection (warmth, spreading redness, fever) No results after 4 weeks Problem: Not seeing expected healing or improvements
This injection has also been shown to have additional benefits
"It can also bind to other receptors responsible for appetite, metabolism, and sexual desire." Mild weight loss is a secondary effect of melanotan